Surefire Medical closes on $12.8M Series D funding

Surefire Medical closes on $12.8M Series D funding

WESTMINSTER -- Surefire Medical, Inc. , developer of site-specific delivery devices for the interventional oncology market, announced the first closing ofa $12.8 million Series D financing round.... Read More

Friday March 10, 2017 0 comments Tags: Westminster, Surefire Medical, ORI Healthcare Fund, Simone Song, James Chomas

Surefire Medical reaches critical commercialization milestone in Germany

Surefire Medical reaches critical commercialization milestone in Germany

WESTMINSTER -- Surefire Medical, Inc. today announced the German Institute of Medical Documentation and Information (DIMDI) has issued a unique classification code (OPS) for the Surefire... Read More

Monday September 12, 2016 0 comments Tags: Westminster, Surefire Medical, James Chomas, Surefire Infusion System

Surefire Medical closes $15M Series C funding for Surefire Precision

Surefire Medical closes $15M Series C funding for Surefire Precision

WESTMINSTER -- Surefire Medical Inc. , a commercial-stage company developing a new class of direct-to-tumor delivery systems used in minimally invasive interventional procedures, announced the... Read More

Thursday December 3, 2015 0 comments Tags: Westminster, Surefire Medical, James Chomas, Tullis Health Invest, John Tullis, Surefire Precision

Surefire Medical launches Precision liver tumor drug delivery infusion system

Surefire Medical launches Precision liver tumor drug delivery infusion system

WESTMINSTER -- Surefire Medical Inc . today announced the launch of its new Precision targeted delivery infusion system for direct-to-tumor embolization procedures. The new technology will be... Read More

Friday September 25, 2015 0 comments Tags: Westminster, Surefire Medical, Precision, James Chomas

Surefire Medical adds Qool Therapeutics CEO Beverly Huss to directors

Surefire Medical adds Qool Therapeutics CEO Beverly Huss to directors

WESTMINSTER - Surefire Medical Inc. announced it has appointed Beverly Huss to its board of directors. "Beverly's experience in developing minimally invasive approaches to treating... Read More

By: InnovatioNews Monday November 17, 2014 0 comments Tags: Beverly Huss, James Chomas, Qool Therapeutics, Surefire Medical, Vibrynt, Westminster